Literature DB >> 21195955

Ultrasound and ovarian cancer screening: is there a future?

Archana Rao1, Jonathan Carter.   

Abstract

Ovarian cancer is a leading cause of death due to gynecologic malignant disease. Advances in ultrasound have improved the ability to identify the more subtle characteristics of adnexal masses, resulting in an increasing volume of research addressing its use to accurately predict whether masses are benign or malignant, and the inclusion of ultrasound in large-scale studies addressing screening for ovarian cancer. Herein, we explore some of the factors that make screening for ovarian cancer challenging, review the major trials addressing the effect of ovarian cancer screening, and examine data relating to more recent advances in ultrasound technology. Crown Copyright Â
© 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21195955     DOI: 10.1016/j.jmig.2010.09.007

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  3 in total

1.  Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.

Authors:  Hanping Wu; Eric C Abenojar; Reshani Perera; Al Christopher De Leon; Tianzhi An; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2019-06-24       Impact factor: 2.998

2.  TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries.

Authors:  Marek Malecki; Mark Anderson; Michael Beauchaine; Songwon Seo; Xenia Tombokan; Raf Malecki
Journal:  J Stem Cell Res Ther       Date:  2012-11-18

3.  Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.

Authors:  Bingcheng Guo; Wei Lian; Shuai Liu; Yingchun Cao; Jianhua Liu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.